Evidence map›Paper›PMID 42440216›Full record

ArticleAnnals of nuclear medicine2026

Prospective evaluation of

André Marcondes Braga Ribeiro, José Augusto Rinck, Stênio de Cássio Zequi

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

André Marcondes Braga RibeiroDepartment of Nuclear Medicine, A.C.Camargo Cancer Center, 211 Professor Antônio Prudente, São Paulo, 01509-010, SP, Brazil. andre.ribeiro@accamargo.org.br.ORCID http://orcid.org/0000-0001-8401-6904
José Augusto RinckDepartment of Clinical Oncology, A.C.Camargo Cancer Center, 211 Professor Antônio Prudente, SP, 01509-010, São Paulo, Brazil.
Stênio de Cássio ZequiDepartment of Urology, A.C.Camargo Cancer Center, 211 Professor Antônio Prudente, SP, 01509-010, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncidental renal masses (RM) are increasingly detected with cross-sectional imaging, and 20-30% of resected small RM are benign, exposing patients to potentially unnecessary surgery. Improved preoperative characterization is needed. Prostate-Specific Membrane Antigen (PSMA) expression in tumor neovasculature enables functional assessment, and

methodsThis was a prospective cross-sectional accuracy study including 24 adults with renal masses scheduled for nephrectomy. All underwent

resultsTwenty-five RM were analyzed in 24 patients, all incidentalomas: 14 (56%) renal cell carcinomas (RCC) - 10 clear cell, 3 papillary, and 1 chromophobe - and 11 (44%) benign lesions.

conclusion

Indexed as

18F-PSMA-1007AngiogenesisImmunohistochemistryPET/CTRenal cell carcinomaRenal mass

Identifiers

PMID42440216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.